Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

Journal of Viral Hepatitis

Volumn 6, Issue 3, 1999, Pages 229-236

  Gong, Z J ^a   De Meyer, S ^a   Clarysse, C ^a   Verslype, C ^a   Neyts, J ^b   De Clercq, E ^b   Yap, S H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

HBV; Mycophenolic acid; Replication

Indexed keywords

GUANOSINE; HEPATITIS B SURFACE ANTIGEN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DRUG HYDROLYSIS; ENZYME INHIBITION; EPISOME; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER CELL; PRIORITY JOURNAL; RNA SYNTHESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; DNA, VIRAL; ENZYME INHIBITORS; GUANOSINE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; MYCOPHENOLIC ACID; RNA, MESSENGER; RNA, VIRAL; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0032974146     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00163.x     Document Type: Article

References (30)

1. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 6: 764-772.
2. Lee B, Luo W, Suzuk S, Robins MJ, Tyrrell DLJ. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrobial Agents Chemother 1989; 33: 336-339.
3. Hoofnagle JH, Minuk GY, Dusheiko GM et al. Adenine arabinoside 5′-monophosphate treatment of chronic type B hepatitis. Hepatology 1982; 2: 784-788.
4. Dusheiko G, DiBisceglie A, Bowyer S et al. Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 1985; 5: 556-560.
5. Lok ASF, Novick DM, Karayiannis P, Dunk AA, Sherlock S, Thomas HC. A randomized study of the effects of adenine arabinoside 5′-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication. Hepatology 1985; 5: 1132-1138.
6. Alexander GJM, Fagan EA, Hegafty JE, Yeo J, Eddeston AL, Williams R. Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. J Med Virol 1987; 21: 81-87.
7. Sherman KE, Jones CC, Goldstein AL, Naylor PH. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus. Viral Immunol 1991; 4: 195-199.
8. Fried MWV, Fong TL, Swain MG et al. Hepatitis B virus (HBV) DNA suppression during long-term therapy with ribavirin. Gastroenterology 1992; 102: A808.
9. Nevens F, Main J, Honkoop P et al. Lamivudine therapy for chronic hepatitis B. A six-month randomized dose ranging study. Gastroenterology 1997; 113: 1258-1263.
10. Cui L, Yoon S, Schinazi RF, Sommadossi JP. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-(-D-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest 1995; 95: 555-563.
11. Gust ID, Burrell CJ, Coulepis AG, Robinson WS, Zuckerman AJ. Taxonomic classification of human hepatitis B virus. Intervirology 1986; 25: 14-19.
12. Ganem D, Varmus HE. The molecular biology of hepatitis B virus. Annu Rev Biochem 1987; 56: 651-693.
13. Allison AC, Almquist JJ, Muller CD, Eugui EM. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 1991; 23 (suppl 2): 10-14.
14. Ichimura H, Levy JA. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus. Virology 1995; 211: 554-560.
15. Rijntjes PJM, Moshage HJ, Yap SH. in vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus. Virus Res 1988; 10: 95-110.
16. Rojkind M, Gatmaitan Z, Mackensen S. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol 1980; 87: 255-263.
17. Mabit H, Dubanchet S, Capel F, Dauguet C, Petit MA. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen producing HepG2 cell line containing integrated HBV-DNA sequences. J Gen Virol 1994; 75: 2681-2689.
18. Hendricks D, Stowe B, Hoo B et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995; 104: 537-546.
19. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005-1009.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 62: 156-159.
21. Kawasaki E. Amplification of RNA. In: Innis MA, Gelfand DH, Snisky JJ, White TJ, eds. PCR Protocols: A Guide to Method and Applications. San Diego: Academic Press, 1990: 21-27.
22. Sallie R. Selective detection of hepatitis B virus RNA by PCR. PCR Methods Appl 1994; 3: 376-377.
23. Köck J, Theilmann PG, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23: 405-413.
24. Gong ZJ, De Meyer S, Roskams T et al. Hepatitis B virus infection in microcarrier attached immortalized human hepatocytes cultured in molecularporous membrane bags: a model for long-term episomal replication of HBV. J Viral Hep 1998; 5: 377-387.
25. Southern EM. Detection of specific DNA sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
26. Kapuscinski J, Skoczylas B. Simple and rapid fluorimetric method for DNA microassay. Anal Biochem 1977; 83: 252-257.
27. Bumgardner GL, Roberts JP. New immunosuppressive agents. Gastroenterol Clin North Am 1993; 22: 421-449.
28. McMillan JS, Shaw T, Angus PW, Locarnini S. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro. Hepatology 1995; 22: 36-43.
29. Neyts J, Meerbach A, Mckenna P, De Clercq E. Use of yellow fever virus vaccine strain 17D for the study of strategies for treatment of yellow fever virus infections. Antiviral Res 1996; 30: 125-132.
30. Neyts J, Andrei G, De Clercq E. The novel immunosuppressive agent mycophenolate mofetil markely potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo. Antimicrob Agents Chemother 1998; 42: 216-222.